98 related articles for article (PubMed ID: 37340282)
1. DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway.
García-Moreno JF; Lacerda R; da Costa PJ; Pereira M; Gama-Carvalho M; Matos P; Romão L
Cell Mol Life Sci; 2023 Jun; 80(7):185. PubMed ID: 37340282
[TBL] [Abstract][Full Text] [Related]
2. Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.
Le Y; Zhang S; Ni J; You Y; Luo K; Yu Y; Shen X
Cell Death Dis; 2018 Jun; 9(6):666. PubMed ID: 29867114
[TBL] [Abstract][Full Text] [Related]
3. Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells.
Chandrasekera P; Perfetto M; Lu C; Zhuo M; Bahudhanapati H; Li J; Chen WC; Kulkarni P; Christian L; Liu J; Yien YY; Yu C; Wei S
J Biol Chem; 2022 Aug; 298(8):102225. PubMed ID: 35780836
[TBL] [Abstract][Full Text] [Related]
4. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.
Xu T; Li X; Zhao W; Wang X; Jin L; Feng Z; Li H; Zhang M; Tian Y; Hu G; Yue Y; Dai X; Shan C; Zhang W; Zhang C; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):126. PubMed ID: 38671459
[TBL] [Abstract][Full Text] [Related]
5. RUNX1-induced upregulation of PTGS2 enhances cell growth, migration and invasion in colorectal cancer cells.
Zheng W; Guo Y; Kahar A; Bai J; Zhu Q; Huang X; Li Y; Xu B; Jia X; Wu G; Zhang C; Zhu Y
Sci Rep; 2024 May; 14(1):11670. PubMed ID: 38778047
[TBL] [Abstract][Full Text] [Related]
6. RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer.
Di Donato M; Di Zazzo E; Salvati A; Sorrentino C; Giurato G; Fiore D; Proto MC; Rienzo M; Casamassimi A; Gazzerro P; Bifulco M; Castoria G; Weisz A; Nassa G; Abbondanza C
J Transl Med; 2023 Oct; 21(1):736. PubMed ID: 37853459
[TBL] [Abstract][Full Text] [Related]
7. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.
Liu W; Chen S; Xie W; Wang Q; Luo Q; Huang M; Gu M; Lan P; Chen D
Cell Mol Biol Lett; 2023 Oct; 28(1):80. PubMed ID: 37828426
[TBL] [Abstract][Full Text] [Related]
8. Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
Vundavilli H; Datta A; Sima C; Hua J; Lopes R; Bittner M
PLoS One; 2021; 16(2):e0247190. PubMed ID: 33596259
[TBL] [Abstract][Full Text] [Related]
9.
Jin L; Huang J; Guo L; Zhang B; Li Q; Li H; Yu M; Xie P; Yu Q; Chen Z; Liu S; Xu Y; Xiao Y; Lu M; Ye Q
J Gastrointest Oncol; 2023 Dec; 14(6):2448-2465. PubMed ID: 38196537
[TBL] [Abstract][Full Text] [Related]
10. The putative oncogenic role of WDTC1 in colorectal cancer.
Wang X; Cai Q; Ping J; Diaz-Zabala H; Xia Y; Guo X
Carcinogenesis; 2022 Jun; 43(6):594-600. PubMed ID: 35238908
[TBL] [Abstract][Full Text] [Related]
11. Research on the Effect and Mechanism of Selenium on Colorectal Cancer Through TRIM32.
Cai X; Su Y; Ning J; Fan X; Shen M
Biol Trace Elem Res; 2024 May; ():. PubMed ID: 38691306
[TBL] [Abstract][Full Text] [Related]
12. Bio Informatics Analysis of the Relationship Between Mammalian Target of Rapamycin and Colorectal Cancer.
Han L; Lin L; Chen J; Yan B
Stud Health Technol Inform; 2023 Nov; 308():322-328. PubMed ID: 38007756
[TBL] [Abstract][Full Text] [Related]
13. Unravelling a novel CTNND1-RAB6A fusion transcript: Implications in colon cancer cell migration.
Rai S; Singh MP; Sinha A; Srivastava A; Datta D; Srivastava S
Int J Biol Macromol; 2024 Mar; 262(Pt 2):129981. PubMed ID: 38336316
[TBL] [Abstract][Full Text] [Related]
14. RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF-
Wang Z; Sheng C; Kan G; Yao C; Geng R; Chen S
Adv Sci (Weinh); 2020 Sep; 7(17):2000593. PubMed ID: 32995120
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.
Donnard E; Asprino PF; Correa BR; Bettoni F; Koyama FC; Navarro FC; Perez RO; Mariadason J; Sieber OM; Strausberg RL; Simpson AJ; Jardim DL; Reis LF; Parmigiani RB; Galante PA; Camargo AA
Oncotarget; 2014 Oct; 5(19):9199-213. PubMed ID: 25193853
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer Stem Cell Subtypes Orchestrate Distinct Tumor Microenvironments.
Hosohama L; Tifrea DF; Nee K; Park SY; Wu J; Habowski AN; Van C; Seldin MM; Edwards RA; Waterman ML
bioRxiv; 2024 Apr; ():. PubMed ID: 38712298
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Mutations Control Stem Cell Polarization in Colorectal Cancer.
Cancer Discov; 2023 Dec; ():OF1. PubMed ID: 38099707
[TBL] [Abstract][Full Text] [Related]
18. RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy‑dependent AKT signaling pathway.
Deng H; Deng L; Chao H; Yu Z; Huang J; Song Z; Peng L; Zeng T
Cell Death Discov; 2023 Aug; 9(1):292. PubMed ID: 37558664
[TBL] [Abstract][Full Text] [Related]
19. Exploring Cancer Dependency Map genes and immune subtypes in colon cancer, in which
Zhang G; Feng Z; Zeng Q; Huang P
Aging (Albany NY); 2023 Jul; 15(13):6400-6428. PubMed ID: 37441804
[TBL] [Abstract][Full Text] [Related]
20. Small non-coding RNAs encoded by RNA viruses: old controversies and new lessons from the COVID-19 pandemic.
Ruivinho C; Gama-Carvalho M
Front Genet; 2023; 14():1216890. PubMed ID: 37415603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
